Diagnostic and prognostic value of the cerebrospinal fluid concentration of immunoglobulin free light chains in clinically isolated syndrome with conversion to multiple sclerosis

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Makshakov, Gleb ^a   Nazarov, Vladimir ^b   Kochetova, Olga ^a   Surkova, Elena ^b   Lapin, Sergey ^b   Evdoshenko, Evgeniy ^a  

^a Municipal Clinical Hospital No 31   (Russian Federation)

^b PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GADOLINIUM; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; OLIGOCLONAL BAND; IMMUNOGLOBULIN LIGHT CHAIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMYELINATING DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; RECEIVER OPERATING CHARACTERISTIC; RECURRENCE RISK; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; CASE CONTROL STUDY; CEREBROSPINAL FLUID; IMMUNOLOGY; ONSET AGE; YOUNG ADULT;

ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; MALE; MULTIPLE SCLEROSIS; PROGNOSIS; ROC CURVE; YOUNG ADULT;

EID: 84960128320     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143375     Document Type: Article

References (16)

1. Dobson R, Ramagopalan S, Davis A, Giovannoni G. Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: A meta-analysis of prevalence, prognosis and effect of latitude. J Neurol Neurosurg Psychiatry. 2013; 84: 909-914. doi: 10.1136/jnnp-2012-304695 PMID: 23431079
2. Awad A, Hemmer B, Hartung HP, Kieseier B., Bennett J.L., Stuve O. Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis. Journal of Neuroimmunology. 2010; 219: 1-7. doi: 10.1016/j.jneuroim.2009.09.002 PMID: 19782408
3. Hassan-Smith G, Durant L, Tsentemeidou A, Assi LK, Faint JM, Kalra S et al. High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis. Journal of Neuroimmunology. 2014; 276: 175-179. doi: 10.1016/j.jneuroim.2014.08.003 PMID: 25146968
4. Kuhle J, Disanto G, Dobson R, Adiutori R, Bianchi L, Topping J et al. Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study. Multiple Sclerosis Journal. 2015; 4: 1-12.
5. Senel M, Tumani H, Lauda F, Presslauer S, Mojib-Yezdani R, Otto M et al. Cerebrospinal Fluid Immunoglobulin Kappa Light Chain in Clinically Isolated Syndrome and Multiple Sclerosis. PLoS ONE. 2014; 9(4): E88680. doi: 10.1371/journal.pone.0088680 PMID: 24695382
6. Presslauer S, Milosavljevic D, Brucke T, Bayer P, HublWet al. Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis. J Neurol. 2008; 255: 1508-1514 doi: 10. 1007/s00415-008-0954-z PMID: 18685917
7. Zeman D, Hradilek P, Kusnierova P, Piza R, Reguliova K, Woznicova I et al. Oligoclonal free light chains in cerebrospinal fluid as markers of intrathecal inflammation. Comparison with oligoclonal IgG. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Mar; 159(1): 104-113. doi: 10.5507/bp.2014.058 PMID: 25485529
8. Villar LM, Espiño M, Costa-Frossard L, Muriel A, Jeménez J, Álvarez-Cermeno JC. High levels of cerebrospinal fluid free kappa chains predict conversion to multiple sclerosis. Clinica Chimica Acta. 2012; 413: 1813-1816
9. Rudick RA, Medendorp SV, Namey M, Boyle S, Fischer J. Multiple sclerosis progression in a natural history study: Predictive value of cerebrospinal fluid free kappa light chains. Mult Scler. 1995; 1: 150-155. PMID: 9345445
10. Rinker JR 2nd, Trinkaus K, Cross AH. Elevated CSF free kappa light chains correlate with disability prognosis in multiple sclerosis. Neurology. 2006; 67: 1288-1290. PMID: 17030770
11. Presslauer S, Milosavljevic D, Huebl W, Parigger S, Schneider-Koch G, Bruecke T. Kappa Free Light Chains: Diagnostic and Prognostic Relevance in MS and CIS. PLoS ONE. 2014; 9(2): E89945. doi: 10. 1371/journal.pone.0089945 PMID: 24651567
12. Nazarov V, Lapin S, Surkova E, Evdoshenko E, Makshakov G, Totolyan A. Diagnostic and prognostic significance of intrathecal synthesis of immunoglobulin free light chains in MS. Mult Scler. 2014; 20 (1 Suppl): 67-284.
13. Goffette S, Schluep M, Henry H, Duprez T, Sindic CJM. Detection of oligoclonal free kappa chains in the absence of oligoclonal IgG in the CSF of patients with suspected multiple sclerosis. J Neurol Neurosurg Psychiatry. 2004; 75: 308-310. PMID: 14742614
14. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. JS Ann Neurol. 2011 Feb; Vol.69: 92-302.
15. Duranti F, Pieri M, Centonze D, Buttari F, Bernardini S, Dessi M. Determination of kFLC and K Index in cerebrospinal fluid: A valid alternative to assess intrathecal immunoglobulin synthesis. Journal of Neuroimmunology. 2013; 263: 116-12. doi: 10.1016/j.jneuroim.2013.07.006 PMID: 23916392
16. Rudick RA, Cookfair DL, Simonian NA, et al. Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNb-1a) for relapsing multiple sclerosis. J Neuroimmunol 1999; 93:8-14. PMID: 10378864